TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$534.6K
As of 2025-12-31
2020-12-31: -$12.8K2021-12-31: -$275.8K2022-12-31: -$951.3K2023-12-31: -$151.8K2024-12-31: -$375.5K2025-12-31: -$534.6K-$534.6K
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$534.6Kn/m2026-05-15, Balance as of period end
2024-12-31-$375.5Kn/m2026-05-15, Balance as of period end
2023-12-31-$151.8Kn/m2026-05-15, Balance as of period end
2022-12-31-$951.3Kn/m2025-09-23, Balance as of period end
2021-12-31-$275.8Kn/m2025-09-23, Balance as of period end
2020-12-31-$12.8Kn/a2023-05-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$534.6Kn/m
Adia Med, Inc. (ADIA)2025-12-31-$257.7Kn/m
Target Group Inc. (CBDY)2025-12-31-$8.06Mn/m
Healthy Extracts Inc. (HYEX)2025-12-31$24.03Mn/m
China Foods Holdings Ltd. (CFOO)2025-12-31-$1.28Mn/m
Nutra Pharma Corp (NPHC)2025-12-31-$16.83Mn/m
Functional Brands Inc. (MEHA)2025-12-31$1.54Mn/m
Bon Natural Life Ltd (BON)2025-09-30$58.00M+30.8%
Charlie's Holdings, Inc. (CHUC)2025-12-31$3.42Mn/m

Compare RAJAF, ADIA, CBDY, HYEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗